authors | Yuthavong, Y., Vilaivan, T., Kamchonwongpaisan, S., Charman, S.A., McLennan, D.N., White, K.L., Vivas, L., Bongard, E., Chitnumsub, P., Tarnchompoo, B., Thongphanchang, C., Taweechai, S., Vanichtanakul, J., Arwon, U., Fantauzzi, P., Yuvaniyama, J., Charman, W.N., Matthews, D. |
Primary reference | Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target., Yuthavong Y, Tarnchompoo B, Vilaivan T, Chitnumsub P, Kamchonwongpaisan S, Charman SA, McLennan DN, White KL, Vivas L, Bongard E, Thongphanchang C, Taweechai S, Vanichtanankul J, Rattanajak R, Arwon U, Fantauzzi P, Yuvaniyama J, Charman WN, Matthews D, Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16823-8. doi:, 10.1073/pnas.1204556109. Epub 2012 Oct 3. PMID:23035243 |